Telavancin for hospital-acquired pneumonia: Clinical response and 28-day survival

G. Ralph Corey, Marin H. Kollef, Andrew F. Shorr, Ethan Rubinstein, Martin E. Stryjewski, Alan Hopkins, Steven L. Barriere

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Telavancin for hospital-acquired pneumonia: Clinical response and 28-day survival'. Together they form a unique fingerprint.

Medicine & Life Sciences